Toxicogenomics takes center stage.
The Society of Toxicology held a meeting on March 9-13, 2003, in Salt Lake City, U.S.A. to discuss all aspects of toxicology with an emphasis on toxicogenomics, including the current state of high-throughput gene expression screens. The meeting gave the most up-to-date overview of current progress in this field, and gave experts to opportunity to discuss their work on in vitro toxicogenomics, proteomics, immunosuppressive drugs, toxicology and magnetic resonance spectroscopy, the environmental impact of pharmaceuticals, antioxidant-responsive element, and estrogens. Speakers from various companies and institutions were present.
Lehmann
John
J
DrugIntel, Wayne, Pennsylvania 19087, USA. jlehmann@drugintel.com
D015195:Drug Design; D004345:Drug Industry / Q000639:trends; D064420:Drug-Related Side Effects and Adverse Reactions; D020869:Gene Expression Profiling; D006801:Humans; D010597:Pharmacogenetics / Q000639:trends*; D040901:Proteomics / Q000639:trends